Latest news for health care topics. Include medical news , health insurance , therapy and vaccine news

Tuesday, March 13, 2018

LABORIE Medical Technologies to acquire Cogentix Medical Inc., for $214 million

For further data on Cogentix Medical & our products, please visit America at www.cogentixmedical.com. Cogentix Medical undertakes no obligation to update any forward-looking statements as a result of latest data, future developments or otherwise, except as expressly required by law. At or around the same time, Cogentix Medical, Inc. going to file a Tender Offer Solicitation/Recommendation Statement on Schedule 14D-nine by respect to the tender offer. Stockholders ought read those materials carefully while they become obtainable because they going to contain important data, including the various terms & conditions of the tender offer. In addition, stockholders going to be enable to obtain a toll free copy of these documents (while they become obtainable) at the Cogentix Medical, Inc. website at www.cogentixmedical.com.


Cogentix Medical agrees to be sold for $239 million

Minnetonka medical device producer Cogentix Medical has agreed to be acquired with Canada-based Laborie Medical Technologies in a $239 million deal which would pay investors $three.85 per share. The deal value represents a positive reversal for a Nasdaq-listed Inc. which was valued at 71 cents per share amid a proxy contest only 2 years ago. The deal value for Cogentix represents a 28 percent premium over Cogentix's Rate 30-day closing value, the companies says in the deal announcement. Since then Cogentix has been making strategic moves to bolster development, including sales of a latest line of endourology products. Analysts had projected which Cogentix would post about $65 million in income in 2018.

Cogentix Medical agrees to be sold for $239 million

Here's the reason Cogentix Medical Inc. Stock Is Surging Today

as mentioned in What happenedShares of Cogentix Medical Inc. (NASDAQ: CGNT), a small-cap medical-device Inc., jumped this morning following a merger-licence announcement. So whatInvestor AB's Laborie Medical Technologies subsidiary develops & markets pelvic-health-linked devices, that makes Cogentix's flexible endoscopy products a perfect fit. In order to extend its offerings, Laborie offered a fairly standard 28% premium for all outstanding Cogentix Medical shares. further From The Motley FoolCory Renauer has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.





collected by :Lucy William

No comments:

Post a Comment